taxifolin has been researched along with datiscetin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Augereau, JM; Billon, M; Gleye, J; Herbert, JM; Lale, A; Leconte, M | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Akagi, K; Irie, K; Katayama, S; Masuda, Y; Murakami, K; Nakagawa, Y; Sato, M; Takegoshi, K; Uno, M | 1 |
| Akagi, K; Hanaki, M; Irie, K; Murakami, K | 1 |
4 other study(ies) available for taxifolin and datiscetin
| Article | Year |
|---|---|
Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes.
Topics: Amino Acid Sequence; Blood Coagulation; Cell Adhesion; Endotoxins; Flavonoids; Humans; In Vitro Techniques; Interleukin-1; Molecular Sequence Data; Monocytes | 1996 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Site-specific inhibitory mechanism for amyloid β42 aggregation by catechol-type flavonoids targeting the Lys residues.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Catechols; Humans; Lysine; Norleucine; Peptide Fragments; Quercetin | 2013 |
Structural insights into mechanisms for inhibiting amyloid β42 aggregation by non-catechol-type flavonoids.
Topics: Amyloid beta-Peptides; Dose-Response Relationship, Drug; Flavonoids; Molecular Structure; Peptide Fragments; Structure-Activity Relationship | 2016 |